HIF1A and colitis: In conclusion, miR-155 treatment decreased the expression of HIF-1α in DSS-induced colitis mouse colonic tissues while miR-155 antagomir or FG-4497 treatments rescued this reduction, eliciting intestinal barrier protective function.